Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Human and Helicobacter pylori coevolution shapes the risk of gastric disease
2014
Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa?
1999
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Spontaneous Large-Scale Lymphoid Neogenesis and Balanced Autoimmunity versus Tolerance in the Stomach of H+/K+-ATPase-Reactive TCR Transgenic Mouse
2006 StandoutNobel
Breast cancer
2019 Standout
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Helicobacter pylori, T cells and cytokines: the âdangerous liaisonsâ
2004
Inflammation and cancer
2002 StandoutNature
African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths
2009
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Global Cancer Statistics, 2002
2005 Standout
Isolation of Helicobacter pylori from human faeces
1992
Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique
2005
Carcinogenesis, apoptosis and cell proliferation
1998
Head and neck cancer
2008 Standout
Inhibition of Helicobacter pylori and Helicobacter mustelae Binding to Lipid Receptors by Bovine Colostrum
1998
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
High acid secretion may protect the gastric mucosa from injury caused by ammonia produced by Helicobacter pylori in duodenal ulcer patients
1996
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Global cancer statistics
2011 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Surgery in Nigeria
1999
A Good Drug Made Better: The Fulvestrant Dose-Response Story
2014
What Role Does Helicobacter pylori Play in Dyspepsia and Nonulcer Dyspepsia? Arguments For and Against H. pylori Being Associated With Dyspeptic Symptoms
1997
Human papillomavirus and cervical cancer
2007 Standout
Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
1998 Standout
An estimation of the global volume of surgery: a modelling strategy based on available data
2008 Standout
DNA diversity among clinical isolates ofHelicobacter pyloridetected by PCR-based RAPD fingerprinting
1992
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
Immune Regulation by helminth parasites: cellular and molecular mechanisms
2003 Standout
Acid suppression and gastri atrophy: sifting fact from fiction
1998
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy
2000
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Infections as a major preventable cause of human cancer
2000
Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio
2005
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
2015
Identifying suspected breast cancer: development and validation of a clinical prediction rule
2011
The gastro-oesophageal reflux disease complex in sub-Saharan Africa
2001
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism–mutualism continuum
2014
Fulvestrant (Faslodex®)—How to Make a Good Drug Better
2007
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Helicobacter pylori and Mucosal Atrophy in Patients with Gastric Cancer (A Special Study Regarding the Methods for Detecting Helicobacter pylori)
1999
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
2009 Standout
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.
1993 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcers.
1993
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
2010 StandoutNobel
An international association between Helicobacter pylori infection and gastric cancer
1993
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
The oral microbiota: dynamic communities and host interactions
2018 Standout
Helicobacter pylori Infection and Gastric Adenocarcinoma.
2011
Works of Chris Holcombe being referenced
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
2015
Helicobacter pylori: the African enigma.
1992
Low incidence of clinically significant gastroduodenal pathology despite a high incidence of Helicobacter pylori infection
1994
Helicobacter pylori clearance in the treatment of non‐ulcer dyspepsia
1992
Pharmacokinetics of a single dose of fulvestrant prolonged-release intramuscular injection in postmenopausal women awaiting surgery for primary breast cancer
2003
Current patterns of referral in breast disease
2000
H. pylori, the most common bacterial infection in Africa: a random serological study.
1992
Is Experience Overseas Useful for the Trainee Surgeon?
1995
Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)
2018